Although the progressive rise in FGF-23 helps maintain normophosphataemia until the later stages of CKD [54,76,93,94], it leads to the suppression of calcitriol production, promoting secondary hyperparathyroidism. This evidence concerns the gene FGF23 and chronic kidney disease.